Regulation of metastasis by microRNAs in ovarian cancer

44Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detection methods. microRNAs (miRs) are small, non-coding RNAs that regulate gene expression post-transcriptionally. Accumulating data suggest central regulatory roles of miRs in modulating OC initiation, progression, and metastasis. More recently, aberrant miR expression has been also associated with cancer stem cell (CSC) phenotypes and development of CSC chemo-resistance. Here, we review recent advances on miRs and OC metastasis and discuss the concept that miRs are involved in both CSC transformation and subsequent OC metastasis. Finally, we describe the prevalence of circulating miRs and assess their potential utilities as biomarkers for OC diagnosis, prognosis, and therapeutics. © 2014 Wang, Kim and Kim.

Cite

CITATION STYLE

APA

Wang, Y., Kim, S., & Kim, I. man. (2014). Regulation of metastasis by microRNAs in ovarian cancer. Frontiers in Oncology. Frontiers Research Foundation. https://doi.org/10.3389/fonc.2014.00143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free